BrainGate
BrainGate™ is a transformative neurotechnology owned and operated by Tufts University that uses micro-electrodes implanted in the brain to let humans operate external devices such as computers or robotic arms with just their thought. Through years of advanced research, BrainGate™ is at the forefront of enabling severely motor-impaired individuals with the ability to communicate, interact, and function through thought. BrainGate™ is the only technology with an FDA-approved investigational device exemption to conduct human trials of brain-computer interface (BCI) technologies